Sionna Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 154K | 152K | 0 | 147K | 0 | 0 | 0 | 166K |
| Gross Profit | -154K | -152K | 0 | -147K | 0 | 0 | 0 | -166K |
| R&D Expenses | 19.0M | 15.2M | 16.0M | 15.4M | 13.7M | 14.3M | 24.6M | 8.2M |
| Operating Expenses | 29.4M | 23.5M | 23.8M | 21.8M | 19.7M | 18.1M | 28.0M | 11.1M |
| Operating Income | -29.6M | -23.6M | -23.8M | -21.9M | -19.7M | -18.1M | -28.0M | -11.3M |
| Other Income / Gains | 2.8M | 3.2M | 3.5M | 3.8M | 3.2M | 2.3M | 2.5M | 2.7M |
| Net Income | -26.8M | -20.4M | -20.3M | -18.1M | -16.5M | -15.8M | -25.4M | -8.6M |
| EPS (Diluted) | -0.60 | -0.46 | -0.46 | -0.41 | -0.374 | -0.359 | -0.58 | -0.194 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 10.6M | 9.9M | 7.2M | 6.5M | 5.6M | 3.9M | 4.2M | 0 |
| Selling And Marketing Expenses | -154K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 10.5M | 9.9M | 7.2M | 6.5M | 5.6M | 3.9M | 4.2M | 2.9M |
| Other Expenses | 0 | -1.6M | 520K | -147K | 431K | 0 | -756K | 0 |
| Cost And Expenses | 29.6M | 23.6M | 23.8M | 21.9M | 19.7M | 18.1M | 28.0M | 11.3M |
| Interest Income | 2.8M | 3.2M | 3.5M | 3.7M | 3.0M | 2.1M | 2.4M | 2.6M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 154K | -678K | 520K | 147K | 431K | 167K | 169K | 166K |
| Ebitda | -26.6M | -17.9M | -19.8M | -17.9M | -16.1M | -15.7M | -25.3M | -8.4M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -26.8M | -20.4M | -20.3M | -18.1M | -16.5M | -15.8M | -25.4M | -8.6M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.60 | -0.46 | -0.46 | -0.41 | -0.374 | -0.359 | -0.58 | -0.194 |
| Weighted Average Shs Out | 44.9M | 40.0M | 44.5M | 44.1M | 44.1M | 44.1M | 44.1M | 44.1M |
| Weighted Average Shs Out Dil | 44.9M | 40.0M | 44.5M | 44.1M | 44.1M | 44.1M | 44.1M | 44.1M |